Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_companies:shanghai_zerun_biotechnology [2022/11/01 04:07]
liam created
+++ pharmaceutical_companies:shanghai_zerun_biotechnology [2024/11/17 20:12] (current)
liam [Research and development]
@@ Line 1: / Line 1: @@
 ====== Shanghai Zerun Biotechnology ======
-{{ :pharmaceutical_companies:shanghaizerun.jpeg?200|
-}}
+{{ :pharmaceutical_companies:shanghaizerun.jpeg?200|}}
+**Shanghai Zerun Biotechnology Co. Ltd.** is a Chinese biotechnology company based in [[:china:Shanghai]], [[:China]]. It operates as a subsidiary of [[pharmaceutical_companies:Walvax Biotechnology]].
+===== Activities =====
+==== Research and development ====
+The company has received three grants from the [[:Bill & Melinda Gates Foundation]].
+  * September 2015: $5,003,336 to improve women's access to low-cost bivalent [[:HPV vaccine]] in [[:GAVI]]-supported countries((//Shanghai Zerun Biotechnology Co., Ltd.// (2015, September). Bill & Melinda Gates Foundation. https://web.archive.org/web/20221101031710/https://www.gatesfoundation.org/about/committed-grants/2015/09/opp1127764))
+  * October 2019: $2,505,923 to improve women's access to low-cost nonavalent HPV vaccine in GAVI-supported countries((//Shanghai Zerun Biotechnology Co., Ltd.// (2019, October). Bill & Melinda Gates Foundation. https://web.archive.org/web/20221101031958/https://www.gatesfoundation.org/about/committed-grants/2019/10/opp1210446))
+  * May 2020: $1,000,000 to support research and development for [[:COVID-19]] response((//Shanghai Zerun Biotechnology Co., Ltd.// (2020, May). Bill & Melinda Gates Foundation. https://archive.ph/yNHyg))
+In July 2021, the [[:Coalition for Epidemic Preparedness Innovations]] (CEPI) announced that it had partnered with Shanghai Zerun Biotechnology and its parent company, Walvax Biotech, to develop [[:COVID-19 vaccines|COVID-19 vaccine]] candidates against both the original strain of [[:SARS-CoV-2]] and its newer variants.((//CEPI partners with Shanghai Zerun Biotech to develop COVID-19 variant vaccine.// (2021, July 21). CEPI. https://web.archive.org/web/20220611060746/https://cepi.net/news_cepi/cepi-partners-with-shanghai-zerun-biotech-to-develop-covid-19-variant-vaccine/)) As of October 2022, CEPI had provided up to $25.1 million USD towards a candidate called 202-CoV, but had ceased further funding.((//Who we are.// CEPI. Retrieved October 19, 2022, from https://web.archive.org/web/20221019165747/https://cepi.net/about/whoweare/)) The chimeric protein candidate remains in Phase I clinical trials.
+===== External links =====
+  * [[https://wiki.whiteroseintelligence.com/en/Shanghai-Zerun-Biotechnology|White Rose Wiki]]